Statement 21 Sep 2023

Statement at the High-Level Meeting on Universal Health Coverage

On 21 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Universal Health Coverage in New York.

Read more
Expert insight 20 Sep 2023

Health at the UN General Assembly: Innovation and equity for pandemic preparedness

Ahead of the 78th session of the United Nations General Assembly (UNGA78), IFPMA Director General, Thomas Cueni underscores the need for pandemic preparedness plans to support innovation and equity. Global leaders must ensure science and innovation can again deliver at record speed and scale, while supporting voluntary partnerships and enabling scientists to have unhindered access...

Read more
Statement 20 Sep 2023

Statement at the High-Level Meeting on Pandemic Prevention, Preparedness and Response

On 20 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response in New York.

Read more
Expert insight 15 Sep 2023

Increasing access to medicines to support Universal Health Coverage

During the UN General Assembly this month and going forward, progress towards delivering Universal Health Coverage (UHC) will be front of stage. Achieving UHC was a commitment made as part of the 2030 Sustainable Development Goals (SDGs) when adopted in 2015 – so this year marks the half-way point in the journey towards 2030. If...

Read more
Expert insight 15 Sep 2023

Decades of persistence have led to new treatments for Alzheimer’s Disease

Our industry knows better than most that failure is an intrinsic and important part of scientific research and development. Even when the development of a potential new medicine isn’t successful, it can still play a crucial role in understanding a disease and provide important data for the next step of the journey. The journey toward...

Read more
Expert insight 15 Sep 2023

The innovative pharmaceutical industry is a solutions partner for action on NCDs

As the drive toward Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs) intensifies, so too does the urgency to respond to the mounting burden of NCDs, especially in low- and middle-income countries (LMICs) where their impact is most acute. Of the 41 million NCD-related deaths per year globally, 77% are in LMICs....

Read more
Report 14 Sep 2023

Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gap

In the spirit of the Global Week for Action on NCDs, this report reiterates the long-standing commitment of the innovative pharmaceutical industry to bring innovative solutions, bridge the NCDs care gap, and accelerate Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs).

Read more
Infographic 14 Sep 2023

Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gap

Read more
Press release 13 Sep 2023

Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity

Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”

Read more
Press release 11 Sep 2023

IFPMA and Speak Up Africa announce shortlisted candidates for the 2nd edition of the Africa Young Innovators for Health Award

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Speak Up Africa announced 15 candidates shortlisted for the 2nd edition of the Africa Young Innovators for Health Award.

Read more
Expert insight 11 Sep 2023

Accelerating antiviral development is central to pandemic preparedness

As leaders and health experts from across the world gather in New York for the UN General Assembly, they are considering three issues that are critical to the future of global health and global health security. As world leaders discuss political declarations on ending tuberculosis (TB), delivering universal health coverage (UHC) and strengthening pandemic prevention, preparedness...

Read more
Expert insight 6 Sep 2023

The importance of a thriving innovation ecosystem: A look at how Hepatitis C was identified and cured

Innovation often comes in waves, set in motion by science. Such was the case when a cure was found for hepatitis C virus (HCV). It was followed by others in quick succession, giving us multiple tools to successfully tackle the disease. The story of HCV shows us what a thriving innovation ecosystem can achieve –...

Read more